ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

FDA Issues Safety Warning

Michele B. Kaufman, PharmD, BCGP  |  September 25, 2018

The FDA is warning that patients with type 2 diabetes taking SGLT2 inhibitors may be at risk of developing a rare, serious infection, Fournier’s gangrene…

Filed under:Drug Updates Tagged with:Drug SafetyFDAFournier’s gangreneInfectionSGLT2 inhibitorssodium-glucose cotransporter-2 (SGLT2) inhibitorsU.S. Food and Drug Administration (FDA)

Celiac Awareness Makes a Difference for Rheumatology Patients

Carina Stanton  |  September 24, 2018

Celiac disease and gluten sensitivity are difficult to diagnose, but they affect multiple systems and are associated with other autoimmune diseases. Lan Chen, MD, PhD, believes better testing and clearer education will be a gamechanger for celiac patients…

Filed under:Conditions Tagged with:celiac diseaseDiagnosisgluten

Placebos: Their Underappreciated Impact in Pharmaceutical Trials

Placebos: Their Underappreciated Impact in Pharmaceutical Trials

Terence W. Starz, MD, Theodore Pincus, MD, On Behalf Of The ARHP Practice Committee  |  September 20, 2018

Sir William Osler, the father of modern medicine, said “the desire to take medicine is perhaps the greatest feature that separates man from animal.” Determination of the benefit of a medication can be challenging and includes a number of factors, such as pharmacologic activities on the disease pathophysiology, pharmacokinetic properties and patient characteristics.1,2 An additional,…

Filed under:Drug Updates Tagged with:clinical trialsplacebo

Racial Disparities in Rheumatology: What Are We Doing About It?

Mary Beth Nierengarten  |  September 20, 2018

The data tell the story. Despite improvements in overall outcomes for common rheumatologic conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), white patients fare better than minority patients, and sometimes substantially better. Even with new biologic therapies that have significantly altered the course of disease for patients with RA, outcomes for minorities…

Filed under:Conditions Tagged with:ethnicityhealth disparitiesracial disparitiesUCOIN

Compliance Means More than Just Paperwork

Anita Henderson-Sumpter, MHA, MBA, CHC, CPC  |  September 20, 2018

Effective management of healthcare compliance requires an office compliance plan that stays current with changing government regulations, payer requirements, office operations and technology. Many still wonder, why is a compliance program needed—if something isn’t broken, don’t fix it, right? This is not always the case; compliance is an essential part of practice operations, but providing…

Filed under:EthicsFrom the CollegeLegal UpdatesPractice Support Tagged with:ComplianceHIPAA

Help Your Patients Live Well with Rheumatic Disease

David Daikh, MD, PhD  |  September 20, 2018

As rheumatology professionals, we focus on how to achieve better outcomes for our patients: lower disease activity, remission, milder symptoms and prevention of joint damage or serious complications, such as heart disease. Another outcome is just as important: good quality of life. What can we do to engage our current patients and those at risk…

Filed under:President's Perspective Tagged with:lifestylequality of lifeRheumatic Disease Awareness MonthRheumatic Disease Report Card

Vladislav Gajic / Shutterstock.com

Advanced Practice Clinicians May Help Close the Workforce Gap

Paul H. Caldron, DO, PhD, FACP, FACR, MBA  |  September 20, 2018

GLENDALE, ARIZ.—Arizona is a microcosm of America’s challenges in reconciling the rheumatology workforce to growing patient demand, as quantified in the ACR’s Workforce Study of 2015.1 So it was timely this year for the Phoenix Rheumatology Association to sponsor its 1st Annual Strategic Training for Rheumatology Advanced Practice Clinicians Symposium. (Note: Advanced practice clinicians [APCs]…

Filed under:Practice SupportWorkforce Tagged with:Advanced Practice Cliniciansnurse practitionerphysician assistantsworkforce projections

Delayed Care: Research Paints Complex Picture of Treatment Delays

Thomas R. Collins  |  September 11, 2018

AMSTERDAM—A variety of factors lead to delays in patients seeking medical care for rheumatoid arthritis—from the nature of symptoms to coping tendencies—requiring more awareness from physicians when managing patients, researchers said at EULAR: the Annual European Congress of Rheumatology. Longer delays in treatment bring about more emotional distress to patients, missed chances to ease symptoms…

Filed under:ConditionsEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:delayed careEULAREuropepatientRheumatoid Arthritis (RA)

Virginia Society Hires Executive Director

Carina Stanton  |  September 7, 2018

Managing the administrative work necessary to keep members of the Virginia Society of Rheumatologists (VSR) active and engaged was proving a challenge for volunteer rheumatologists balancing their society activities with busy practice schedules. After attending several other state society meetings and talking to society leaders about the value of creating an executive director role, VSR…

Filed under:Profiles Tagged with:Elizabeth Schroeder Craigexecutive director roleRichmond Academy of Medicine Services CorporationVirginia Society of Rheumatologists (VSR)

Maryland Gets an A; Most States Receive a C on ACR’s 1st Rheumatic Disease Report Card

Carina Stanton  |  September 5, 2018

In a first-of-its-kind report card, the ACR shows that many changes are needed for states to improve patient access to affordable and effective rheumatology care…

Filed under:American College of RheumatologyLegislation & AdvocacyPatient PerspectivePractice Support

  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 97
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences